Posted on August 20, 2007
For those who subscribe to articles but not to IP ThinkTank, this post about IBM’s suggestion for a new patent right has generated some interesting discussion.
It has also now been published at ipFrontline.
Category: Global IP Strategy, Pharma, Bio & Chem
You must log in to post a comment.
Enter your email address to receive email updates
Powered by WordPress.com.